Skip to main content

Table 2 Second cancers by race

From: Impact of race and tumor subtype on second malignancy risk in women with breast cancer

 

Under 50

50 and older

White

Black

White

Black

O/E

Excess risk

O/E

Excess risk

O/E

Excess risk

O/E

Excess risk

All sites

1.55#

38.59

2.30#

76.03

1.07#

11.56

1.30#

42.26

All solid tumors

1.59#

37.78

2.37#

72.87

1.10#

14.23

1.34#

42.99

Oral cavity and pharynx

1.25#

0.28

0.98

−0.02

1.05

0.12

0.93

−0.13

Digestive system

1.04

0.35

1.08

0.87

0.97#

−1.18

1.10#

3.71

Colon, rectum and anus

0.91#

−0.53

0.98

−0.12

0.97#

−0.62

1.07

1.51

Pancreas

1.17#

0.23

1.04

0.06

0.92#

−0.39

1.07

0.47

Peritoneum, omentum and mesentery

2.11#

0.18

1.96

0.07

0.92

−0.03

1.06

0.01

Respiratory system

1.23#

1.93

1.69#

5.53

0.95#

−1.1

1.08

1.73

Bones and joints

1.93#

0.08

2.04

0.07

1.1

0.01

1.22

0.03

Soft tissue including heart

2.16#

0.4

1.81

0.32

1.34#

0.24

1.75#

0.54

Skin excluding basal and squamous

1.20#

0.67

2.03

0.29

1.11#

0.51

1.71#

0.38

Breast

2.18#

30.16

3.91#

60.98

1.30#

12.67

1.89#

31.31

Female genital system

1.32#

3.14

1.47#

3.36

1.17#

2.93

1.22#

3.41

Corpus and uterus, NOS

1.16#

0.84

1.70#

2.24

1.32#

3.02

1.48#

3.69

Ovary

1.97#

2.5

2.00#

1.49

1.07#

0.33

0.97

-0.12

Urinary system

1.13#

0.38

1.14

0.32

1.02

0.19

1.23#

1.68

Brain and other nervous system

1.12

0.1

0.17#

−0.34

0.75#

-0.4

0.75

−0.23

Endocrine system

1.15#

0.35

2.00#

1.53

1.25#

0.45

1.50#

0.82

Lymphoma

0.93

-0.19

0.96

-0.07

0.89#

-0.77

1.04

0.16

Leukemia

1.63#

0.84

3.95#

2.65

1.05

0.23

1.19

0.58

  1. # Indicates P value <0.05